Javier Dotor

2.7k total citations
47 papers, 2.2k citations indexed

About

Javier Dotor is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Javier Dotor has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Surgery. Recurrent topics in Javier Dotor's work include TGF-β signaling in diseases (15 papers), Cancer Cells and Metastasis (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Javier Dotor is often cited by papers focused on TGF-β signaling in diseases (15 papers), Cancer Cells and Metastasis (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Javier Dotor collaborates with scholars based in Spain, United States and Germany. Javier Dotor's co-authors include Francisco Borrás‐Cuesta, Juan José Lasarte, Jesús Prìeto, Pablo Sarobe, Gabriel Gallo-Oller, Raquel Ordóñez, Pilar Sandoval, Manuel López‐Cabrera, Noëlia Casares and Pedro Majano and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Javier Dotor

45 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Dotor Spain 28 936 573 511 347 243 47 2.2k
Shigehisa Aoki Japan 27 793 0.8× 541 0.9× 453 0.9× 484 1.4× 184 0.8× 131 2.7k
Anita B. Roberts United States 12 1.5k 1.6× 577 1.0× 688 1.3× 265 0.8× 324 1.3× 12 3.0k
Kazuo Muroi Japan 21 819 0.9× 502 0.9× 444 0.9× 454 1.3× 172 0.7× 160 2.5k
Reinier Raymakers Netherlands 33 1.5k 1.6× 891 1.6× 748 1.5× 213 0.6× 254 1.0× 109 3.6k
Silvia D’Alessio Italy 25 796 0.9× 601 1.0× 448 0.9× 308 0.9× 528 2.2× 49 2.1k
Masahiro Masuya Japan 26 768 0.8× 433 0.8× 694 1.4× 222 0.6× 107 0.4× 115 2.5k
Monika Lodyga Canada 20 876 0.9× 234 0.4× 420 0.8× 240 0.7× 199 0.8× 28 2.0k
Nives Jonjić Croatia 24 732 0.8× 1.0k 1.8× 908 1.8× 314 0.9× 378 1.6× 124 2.6k
Arseniy E. Yuzhalin Russia 27 761 0.8× 797 1.4× 853 1.7× 372 1.1× 417 1.7× 70 2.6k
Laura Denby United Kingdom 24 1.7k 1.8× 475 0.8× 765 1.5× 428 1.2× 581 2.4× 55 3.1k

Countries citing papers authored by Javier Dotor

Since Specialization
Citations

This map shows the geographic impact of Javier Dotor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Dotor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Dotor more than expected).

Fields of papers citing papers by Javier Dotor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Dotor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Dotor. The network helps show where Javier Dotor may publish in the future.

Co-authorship network of co-authors of Javier Dotor

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Dotor. A scholar is included among the top collaborators of Javier Dotor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Dotor. Javier Dotor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dotor, Javier, et al.. (2022). P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model. Current Oncology. 29(4). 2650–2661. 8 indexed citations
2.
Sevilla, Pablo, et al.. (2018). In vitro cell response on CP-Ti surfaces functionalized with TGF-β1 inhibitory peptides. Journal of Materials Science Materials in Medicine. 29(6). 73–73. 17 indexed citations
3.
Gallo-Oller, Gabriel, Raquel Ordóñez, & Javier Dotor. (2018). A new background subtraction method for Western blot densitometry band quantification through image analysis software. Journal of Immunological Methods. 457. 1–5. 143 indexed citations
4.
Neill, Daniel R., William R. Coward, Jenna F. Gritzfeld, et al.. (2014). Density and Duration of Pneumococcal Carriage Is Maintained by Transforming Growth Factor β1 and T Regulatory Cells. American Journal of Respiratory and Critical Care Medicine. 189(10). 1250–1259. 43 indexed citations
5.
Gallo-Oller, Gabriel, Juan A. Rey, Javier Dotor, & Javier S. Castresana. (2014). Quantitative method for in vitro matrigel invasiveness measurement through image analysis software. Molecular Biology Reports. 41(10). 6335–6341. 6 indexed citations
6.
Zarranz‐Ventura, Javier, Patricia Fernández‐Robredo, Sergio Recalde, et al.. (2013). Transforming Growth Factor-Beta Inhibition Reduces Progression of Early Choroidal Neovascularization Lesions in Rats: P17 and P144 Peptides. PLoS ONE. 8(5). e65434–e65434. 31 indexed citations
7.
Otano, Itziar, Javier Dotor, Manuela González-Aparicio, et al.. (2012). Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B. Hepatology. 56(2). 474–483. 18 indexed citations
8.
Margheri, Francesca, Nicola Schiavone, Laura Papucci, et al.. (2012). GDF5 Regulates TGFß-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGFß Peptides. PLoS ONE. 7(11). e50342–e50342. 28 indexed citations
9.
Díaz‐Valdés, Nancy, Javier Dotor, Fernando Aranda, et al.. (2010). Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression. Cancer Research. 71(3). 812–821. 55 indexed citations
10.
Arribillaga, Laura, Javier Dotor, José Ignacio Riezu‐Boj, et al.. (2010). Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis. Cytokine. 53(3). 327–333. 63 indexed citations
11.
Vicent, Silvestre, Diego Luis-Ravelo, Iker Antón, et al.. (2008). A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism. Cancer Research. 68(7). 2275–2285. 81 indexed citations
12.
Gil‐Guerrero, Lucía, Javier Dotor, Inge L. Huibregtse, et al.. (2008). In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-β1. The Journal of Immunology. 181(1). 126–135. 57 indexed citations
13.
Ávila, Matías A., María Íñiguez, Javier Dotor, et al.. (2008). Novel Pharmacologic Strategies to Protect the Liver from Ischemia- Reperfusion Injury. Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery). 3(1). 9–18. 15 indexed citations
14.
Serratì, Simona, Francesca Margheri, Marco Pucci, et al.. (2008). TGFβ1 antagonistic peptides inhibit TGFβ1-dependent angiogenesis. Biochemical Pharmacology. 77(5). 813–825. 43 indexed citations
15.
Hermida, Nerea, Begoña López, Arantxa González, et al.. (2008). A synthetic peptide from transforming growth factor- 1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovascular Research. 81(3). 601–609. 91 indexed citations
16.
Pérez-Gómez, Eduardo, María Villa‐Morales, Javíer Santos, et al.. (2007). A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis. Cancer Research. 67(21). 10268–10277. 44 indexed citations
17.
Zabaleta, Aintzane, Laura Arribillaga, Diana Llópiz, et al.. (2007). Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Antiviral Research. 74(1). 25–35. 12 indexed citations
18.
Ocaña‐Morgner, Carlos, et al.. (2007). Role of TGF‐β and PGE2 in T cell responses during Plasmodium yoelii infection. European Journal of Immunology. 37(6). 1562–1574. 32 indexed citations
19.
Santiago, Begoña, Irene Gutiérrez‐Cañas, Javier Dotor, et al.. (2005). Topical Application of a Peptide Inhibitor of Transforming Growth Factor-β1 Ameliorates Bleomycin-Induced Skin Fibrosis. Journal of Investigative Dermatology. 125(3). 450–455. 138 indexed citations
20.
Lasarte, Juan José, Javier Dotor, Inma Castilla‐Cortázar, et al.. (2003). A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine. 22(1-2). 12–20. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigehisa Aoki Breakdown of academic impact, for papers by Anita B. Roberts Breakdown of academic impact, for papers by Kazuo Muroi Breakdown of academic impact, for papers by Reinier Raymakers Breakdown of academic impact, for papers by Silvia D’Alessio Breakdown of academic impact, for papers by Masahiro Masuya Breakdown of academic impact, for papers by Monika Lodyga Breakdown of academic impact, for papers by Nives Jonjić Breakdown of academic impact, for papers by Arseniy E. Yuzhalin Breakdown of academic impact, for papers by Laura Denby
Rankless by CCL
2026